EU remote
Director, Medical Affairs, Poland
About this role
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients. The Opportunity: Reporting to the Country Manager Poland, the Director, Medical Affairs, Poland is the medical leader responsible for defining and executing the local medical strategy RevMed portfolio and launches. This role serves as the medical voice within the Poland Leadership Team, ensuring scientific excellence, compliant medical engagement, and strong alignment between global strategy and local patient, physician, and healthcare system needs.
This leader will ensure that Poland medical considerations are embedded in the regional medical strategy and plans and will partner with the Country Manager and crossfunctional teams, as well as the Sr Dir Medical Affairs Midsized Markets and VP Head of Europe Medical Affairs and their leadership team. The incumbent will contribute to building the Poland medical team and work closely with the Midsized Markets crossfunctional and cross-country teams, Global and Regional Medical Affairs teams across Med Affairs functions.
Required Experience: Act as the Medical Affairs lead for Poland, accountable for local medical strategy, execution, and impact across the oncology portfolio. Translate global medical and clinical strategies into locally relevant medical plans aligned with country regulations and clinical practice . Build and maintain strong relationships with national and regional key opinion leaders, oncology networks, academic institutions, and scientific societies.